Anne Vanlent insider trades: Trevi Therapeutics (TRVI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anne reports to the SEC
and 7 more companies
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 9, 2019 | TRVI | ↑ Buy | 5,000 | $10.00 | $50K | Direct | May 13, 2019 (4d) |
| Jun 22, 2015 | BOTA | ↑ Buy | 35,000 | $2.20 | $77K | Direct | Jun 24, 2015 (2d) |
| May 8, 2014 | AEGR | ↑ Buy | 4,000 | $33.78 | $135K | Direct | May 9, 2014 (1d) |
| Jan 13, 2011 | IART | ↓ Sell | 5,270 | $47.49 | $250K | Direct | Jan 14, 2011 (1d) |
| Nov 6, 2008 | PPCO | ↓ Sell | 6,900 | $1.01 | $7K | Direct | Nov 10, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TRVI insiders
Open-market trades in the last 12 months
About Anne Vanlent's insider trades
Anne Vanlent is an insider at Trevi Therapeutics (TRVI). Since Nov 6, 2008, Anne has reported 3 open-market purchases worth $262K and 2 sales worth $257K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (70 filings), shares returned to the company (3 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRVI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.